CUREVAC NV-
CUREVAC NV-
Share · NL0015436031 · CVAC · A2P71U (XNAS)
Overview Financial Indicators
4,24 USD
-4,78 % -0,21 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 23:21

Current Prices from CUREVAC NV-

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
CVAC
USD
06.06.2025 23:21
4,24 USD
4,47 USD
-5,08 %
XETR: XETRA
XETRA
5CV.DE
EUR
06.06.2025 15:35
3,85 EUR
3,87 EUR
-0,62 %
XFRA: Frankfurt
Frankfurt
5CV.F
EUR
06.06.2025 15:10
3,84 EUR
3,87 EUR
-0,67 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % -4,76 % 26,13 % 32,03 % 35,84 % -8,51 % -92,01 %

Company Profile for CUREVAC NV- Share

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 clinical trial against influenza, as well as vaccine for lassa fever, yellow fever, respiratiory syncytial virus, rotavirus, malaria, and universal influenza. The company also develops RNA-based cancer immunotherapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck. The company was founded in 2000 and is headquartered in Tübingen, Germany.

Company Data

Name CUREVAC NV-
Company CureVac N.V.
Symbol CVAC
Website https://www.curevac.com
Primary Exchange XNAS NASDAQ
WKN A2P71U
ISIN NL0015436031
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Alexander Zehnder M.B.A., M.D.
Market Capitalization 613 Mio
Country Germany
Currency USD
Employees 0,8 T
Address Friedrich-Miescher-Strasse 15, 72076 Tübingen
IPO Date 2020-08-25

Ticker Symbols

Name Symbol
Frankfurt 5CV.F
NASDAQ CVAC
XETRA 5CV.DE

More Shares

Investors who CUREVAC NV- hold also have the following shares in their portfolio:
ALIBABA GR. SP.ADR 8
ALIBABA GR. SP.ADR 8 Share
AMAZON.CO INC
AMAZON.CO INC Share
APPLE INC
APPLE INC Share
BARCLAYS BANK PLC 5.43% CALL NTS 19/01/2032
BARCLAYS BANK PLC 5.43% CALL NTS 19/01/2032 Bond
BIONTECH SE ADR
BIONTECH SE ADR Share
INVESTEC BANK PLC IMP DUAL IDX 7YR PHX KO NTS CAR 26/05/26
INVESTEC BANK PLC IMP DUAL IDX 7YR PHX KO NTS CAR 26/05/26 Bond
META PLATFORMS INC
META PLATFORMS INC Share
MICROSOFT CORP
MICROSOFT CORP Share
NUTANIX INC - CLASS A
NUTANIX INC - CLASS A Share
NVIDIA CORP
NVIDIA CORP Share
QIAGEN NV
QIAGEN NV Share
TENCENT . LTD
TENCENT . LTD Share
TESLA INC
TESLA INC Share
XIAOMI CORP CL.B
XIAOMI CORP CL.B Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025